Paul Brookes
Impact in
- Transplantation top 0.2%
- Renal Transplantation Outcomes and Treatments
- Hematology top 2%
- Hematopoietic Stem Cell Transplantation
Papers in
-
- Renal Transplantation Outcomes and Treatments 27
- Hematology 17
- Hematopoietic Stem Cell Transplantation 15
- Co-authors
- Robert I. LechlerMichelle WillicombeDavid TaubeCandice RoufosseAdam McLeanJack GallifordEva Santos‐NunezJohn M. Goldman
- Journals
- Transplantation (22 papers)American Journal of Transplantation (7 papers)Kidney International (3 papers)Journal of the American Society of Nephrology (2 papers)British Journal of Haematology (1 paper)
- Partner nations
- United KingdomUnited StatesItaly
In The Last Decade
Paul Brookes
55 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 72
- Transplantation 896
- Hematology 514
- Nephrology 323
- Immunology 939
- Surgery 493
Countries citing papers authored by Paul Brookes
This map shows the geographic impact of Paul Brookes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Brookes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Brookes more than expected).
Fields of papers citing papers by Paul Brookes
This network shows the impact of papers produced by Paul Brookes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Brookes. The network helps show where Paul Brookes may publish in the future.
Co-authors
The 25 scholars most cited alongside Paul Brookes, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2023 | 4 | |
| 3 | 2022 | 1 | |
| 4 | 2018 | 26 | |
| 5 | 2017 | 107 | |
| 6 | 2015 | 31 | |
| 7 | 2014 | 29 | |
| 8 | Rituximab or Alemtuzumab Induction for ABO Incompatible Renal Transplantation | 2013 | 1 |
| 9 | 2013 | 49 | |
| 10 | Chronic Antibody-Mediated Rejection: B-Cell Dependent Alloreactive IFN gamma-Producing CD4+ T Cells Could Be Used as a Biomarker To Determine Responsiveness to Therapy | 2012 | 1 |
| 11 | 2011 | 42 | |
| 12 | 2011 | 41 | |
| 13 | 2001 | 160 | |
| 14 | 2001 | 91 | |
| 15 | 2001 | 46 | |
| 16 | Assessment of the immunological contribution to Chronic Allograft Nephropathy | 2000 | 4 |
| 17 | 1998 | 19 | |
| 18 | 1997 | 10 | |
| 19 | 1996 | 23 | |
| 20 | 1991 | 47 |
About Paul Brookes
Paul Brookes is a scholar working on Transplantation, Hematology, Nephrology, Immunology and Physiology, having authored 56 papers that have together received 1.9k indexed citations. Recurring topics across this work include Renal Transplantation Outcomes and Treatments (27 papers), T-cell and B-cell Immunology (21 papers), Hematopoietic Stem Cell Transplantation (15 papers), Immunotherapy and Immune Responses (13 papers), Renal Diseases and Glomerulopathies (10 papers), Transplantation: Methods and Outcomes (10 papers), Immune Cell Function and Interaction (9 papers) and Organ Transplantation Techniques and Outcomes (8 papers). The work is most often cited by research in Transplantation (896 citations), Hematology (514 citations), Nephrology (323 citations), Immunology (939 citations) and Surgery (493 citations). Paul Brookes has collaborated with scholars based in United Kingdom, United States and Italy. Frequent co-authors include Robert I. Lechler, Michelle Willicombe, David Taube, Candice Roufosse, Adam McLean, Jack Galliford, Eva Santos‐Nunez, John M. Goldman, María P. Hernández-Fuentes and Richard J. Baker. Their work appears in journals such as Transplantation, American Journal of Transplantation, Kidney International, Journal of the American Society of Nephrology and British Journal of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.